Nutrigenomix: Personalized Nutrition Assessment

Vive Crop Protection: Vive's Line of Fertilizer Compatible (FC) Products

Ahead: AI-assisted hematologic analytic and decision support

LaserLight, the world’s brightest and most innovative light source

The next generation in lighting has arrived, shining brighter and farther than ever before. In the last decade, LED enabled a new generation of lighting that changed everything. Now, LaserLight outshines the limits of LED to deliver safe, high luminance white light from an incredibly small point source. LaserLight doesn’t just offer superior technology, it’s enabling entirely new opportunities. 
As an independent spin-off from Soraa Inc, SLD Laser was founded in 2013 by several leading global pioneers in solid-state lighting, including Dr. Shuji Nakamura, a 2014 Nobel Laureate in Physics for his groundbreaking work with LEDs, Dr. Steve Denbaars, Dr. James Raring, and Dr. Paul Rudy. The laser technology incorporates a robust intellectual property portfolio of over 500 patents


Achilles Heel Technologies: internet security for large companies

Achilles Heel Technologies, LLC (BYU technology) uses cutting-edge math and unique software to show you where your cyber-human-physical systems are most vulnerable to attack. Cybersecurity is essential because the threats are real - and growing. Malicious actors, ranging from individual hackers to established governments, regularly attempt to penetrate public and private infrastructure. They’re often successful. The complexity of modern systems, with all of their cyber, physical, and human components, usually presents many avenues of attack, some of which will be much more damaging than others.


A new device that detects infectious diseases

Infectious diseases can spread very rapidly, so quickly identifying them can be crucial to stopping an epidemic. However, current testing for such diseases can take hours and days. Jayne Wu, associate professor of computer science and electrical engineering at the University of Tennessee (UnTen), Knoxville, and Shigetoshi Eda, associate professor of Forestry, Wildlife and Fisheries at the UT Institute of Agriculture Center for Wildlife Health, have developed a portable device that can be used onsite to detect infectious diseases such as tuberculosis (lat. Phthisis), pathogens, as well as physiological conditions in people and animals. This device has the potential to save a lot of lives by saving time in detection. It also saves a lot of money as it is cheaper to detect diseases than the system that is currently being used since don't have to send them to a lab and have the sample be scrutinized by technicians.


A Child Wearable to Keep Kids Close

Students build smaller, equally powerful version of Village Drill

Brain Corp: Transforming everyday machines into autonomous solutions

Beam Therapeutics uses CRISPR base editing to develop genetic medicines

Beam Therapeutics is developing precision genetic medicines through base editing. Founded by leading scientists in CRISPR gene editing, Beam Therapeutics is pursuing therapies for serious diseases using its proprietary base editing technology, which can make precise edits to single base pairs in DNA and RNA. Headquartered in Cambridge, Massachusetts, the company is backed by F-Prime Capital Partners and ARCH Venture Partners, two of the world’s leading biotech venture capital firms. In addition, Beam Therapeutics has already raised a total of $87 million in Series A round.


Genprex: developing the immunogene therapy for cancer

Genprex, Inc. is a clinical stage gene therapy company developing a new approach to treating cancer, based upon a novel proprietary technology platform, including Genprex’s initial product candidate, Oncoprex™ immunogene therapy for non-small cell lung cancer (NSCLC). Genprex’s platform technologies are designed to administer cancer-fighting genes by encapsulating them into nanoscale hollow spheres called nanovesicles, which are then administered intravenously and taken up by tumor cells where they express proteins that are missing or found in low quantities. Oncoprex™ has a multimodal mechanism of action whereby it interrupts cell signaling pathways that cause replication and proliferation of cancer cells, re-establishes pathways for apoptosis, or programmed cell death, in cancer cells, and modulates the immune response against cancer cells. Oncoprex™ has also been shown to block mechanisms that create drug resistance.


A mobile application to support education of dyslexic children

Dyslexia is defined as a neurological difference in acquiring reading, spelling and writing skills by the European Dyslexia Association, and is seen in individuals with both average and above-average intellect. Thought to have affected geniuses such as Einstein, Mozart and Leonardo da Vinci, dyslexia is usually discovered in the first years of primary school as it affects reading skills. However, Sabancı University Faculty of Engineering and Natural Sciences Computer Science and Engineering PhD Candidate Günet Eroğlu developed 'Auto Train Brain', a mobile application for dyslexic children having academic and learning difficulties.


Cookies help us deliver our Services. By using our website or clicking I agree, you agree to our use of cookies. Learn more about our cookie and privacy policy.